首页>
外国专利>
MSH3 EXPRESSION STATUS DETERMINES THE RESPONSIVENESS OF CANCER CELLS TO THE CHEMOTHERAPEUTIC TREATMENT WITH PARP INHIBITORS AND PLATINUM DRUGS.
MSH3 EXPRESSION STATUS DETERMINES THE RESPONSIVENESS OF CANCER CELLS TO THE CHEMOTHERAPEUTIC TREATMENT WITH PARP INHIBITORS AND PLATINUM DRUGS.
展开▼
机译:MSH3的表达状态可确定癌症细胞对PARP抑制剂和铂药物进行化学疗法的反应。
展开▼
页面导航
摘要
著录项
相似文献
摘要
Methods for treating a patient at risk for or diagnosed with colorectal cancer are disclosed herein. The method of the present invention determines the overall expression of MSH3 in cells suspected of being colorectal cancer cells from the patient and predicting the efficacy of therapy with a genotoxic anti-neoplastic agent for treating the patient, wherein a decrease in the overall expression of MSH3 in the patient cells when compared to the expression of MSH3 in normal colorectal cells indicates a predisposition to responsiveness to genotoxic anti-neoplastic agent therapy, wherein the therapy comprises administering an effective amount of the genotoxic anti-neoplastic agent therapy to patients.
展开▼